BioPatch – a bio-instructive resorbable implant for enhancing surgical repair of rotator cuff tendon
BioPatch aids rotator cuff repair with strength and bioactive support.
Home>Biologicals
Adenovirus-vectored vaccine manufacturing production and purification process
Improved methods of manufacturing and purification processes for adenoviral vectored vaccines, oncolytic viruses and gene therapies to high Titre, with low cost of goods.
A novel vaccine against Neisseria gonorrhoeae
Neisseria gonorrhoeae vaccine using outer membrane vesicles (OMVs) derived from a genetically modified strain of Neisseria.
Cross-strain HIV therapeutic vaccine for all geographical regions
Chimeric immunogenic polypeptides, created using the HIVconsv method, are now in clinical trials, offering strong and broad protection against HIV.
New RH5-based malaria prophylaxis with stronger infection inhibition
New malaria vaccine designed with stronger infection inhibition
Stabilised class III viral fusion proteins for more effective immunisation of rabies disease
Stabilised viral fusion proteins for improved vaccines and protective antibodies against human and veterinary pathogens.
Further improved peptide tag technology: SpyTag and SpyCatcher version 3
An increased reaction rate of SpyTag and SpyCatcher by more than two orders of magnitude, whilst retaining all the advantageous features of their predecessors.
A method for precisely tuning gene expression levels in mammalian cells
Researchers at the University of Oxford have developed a method for precise, stepwise control of endogenous gene expression levels using engineered microRNA response elements.
Acute myeloid leukaemia prognostic and diagnostic screening
Oxford researchers, in collaboration with the University of Birmingham, have discovered novel combinations of cell-surface biomarkers (CD molecules) that allow AML to be stratified into 3 different molecular sub-types to allow targeted treatment and better monitoring of treatment response.
Hepatitis C vaccine
A viral-vectored vaccine incorporating a novel immunogen for a pan-genotypic Hepatitis C protection based on genomic segments that are conserved between HCV genotypes.
© Oxford University Innovation